β-adrenoceptor blocking agents for the treatment of heart failure

International Journal of Clinical Pharmacology and Therapeutics

Volumn 34, Issue 6, 1996, Pages 231-235

  Heilbron, B G ^a   Gin, K G ^a  

^a Cardiac Ultrasound   (Canada)

Author keywords

adrenoceptor blocking agents; Congestive heart failure; Neurohormonal activation

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; NEUROHORMONE;

ADRENERGIC SYSTEM; ARTICLE; CONGESTIVE HEART FAILURE; DOWN REGULATION; HEART FAILURE; HEART TRANSPLANTATION; HUMAN; MORBIDITY; MORTALITY; SURVIVAL; SYMPTOM;

ADRENERGIC BETA-ANTAGONISTS; HEART FAILURE, CONGESTIVE; HUMANS;

EID: 0029953818     PISSN: 09461965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. Alderman J, Grossman W 1985 Are beta adrenergic blocking drugs useful in the treatment of dilated cardiomyopathy? Circulation 71: 854-847
2. Anderson JL, Lutz JR, Gilbert EM et al 1985 A randomized trial of low dose beta blockade therapy for idiopathic dilated cardiomyopathy. Am J Cardiol 55: 471-475
3. Bennett SK, Fisher ML, Krichten C, Pallen RD, Greenberg NL, Gottlieb SS 1993 Heart failure and non-cardiac disease: Comparison of changes in the ejection fraction with the beta blocker and placebo (Abstract). J Am Coll Cardiol 21 (Suppl A): 114A
4. Boissel JP, Leizorovicz A, Picolel H, Peyrieux JC For the ASSI Investigators 1990 Secondary prevention after high risk acute myocardial infarction with low-dose acebutolol. Am J Cardiol 653: 251-260
5. Bristow MR, Gilbert EM, French WJ, Leatherman G, Kantrowitz NE, Deitchman D and the Bucindolol Study Group 1990 Dose response to beta blocker therapy in heart failure: a multicentre randomized trial of bucindolol versus placebo (Abstract). Circulation 82 (Suppl III): III-674
6. Bristow MR, Anderson FL, Port D et al 1991 Differences in beta adrenergic and neuroeffector mechanisms in ischemic versus dilated cardiomyopathy. Circulation 84: 1024-1039
7. Bristow MR 1993 Pathophysiologic and pharmacologic rationales for clinical management of chronic heart failure with beta blocking agents. Am J Cardiol 87: 12C-22C
8. Chadda K, Goldstein S, Byington K, Curb JD 1986 Effect of propanolol after acute myocardial infarction in patients with congestive heart failure. Circulation 73: 503-510
9. CIBIS Investigators and Committees 1994 A randomized trial of β-blockade in heart failure. Circulation 90: 1765-1772
10. Currie PJ, Kelly MJ, McKenzie A et al 1984 Oral beta adrenergic blockade with metoprolol and chronic severe dilated cardiomyopathy. J Am Coll Cardiol 3: 203-209
11. Doughty RN, MacMahon S, Sharpe N 1994 Beta blockers in heart failure: promising or proved? JACC 23: 814-821
12. Eichhorn EJ, Bedotto JB, Malloy CR et al 1990 Effect of beta adrenergic blockade on myocardial function and energetics in congestive heart failure. Improvements in hemodynamic, contractile and diastolic performance with bucindolol. Circulation 82: 473-483
13. Eichhorn E 1992 The paradox of β-adrenergic blockage for the management of congestive heart failure. Am J Med 92: 527-583
14. Engelmeier RS, O'Connell JB, Walsh R, Rad N, Scanlon PJ, Gunnar RN 1985 Improvement in symptoms and exercise tolerance via metoprolol in patients with dilated cardiomyopathy: a double-blind randomized placebo controlled trial. Circulation 72: 536-546
15. Fisher M, Gottlieb S, Plotnick G, Greenberg N, Patten R, Bennett S, Hamilton B 1994 Beneficial effects of metoprolol in heart failure associated with coronary artery disease: a randomized trial. J Am Coll Cardiol 23: 943-950
16. Fowler W 1993 Controlled trials with beta blockers and heart failure; metoprolol as the prototype. Am J Cardiol 71: 45C-53C
17. Francis GS, Benedict C, Johnstone DE et al for the SOLVD Investigators 1990 Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure; a sub-study of The Studies of Left Ventricular Dysfunction (SOLVD). Circulation 82: 1724-1729
18. Gilbert EM, Anderson JL, Deitchman D et al Long-term beta blocker vasodilator therapy improves cardiac function and idiopathic dilated cardiomyopathy: a double-blind, randomized study of bucindolol versus placebo. Am J Med 88: 223-229
19. Ikbam H, Fitzpatrick D 1981 Double-blind trial of chronic oral beta-blockade in congestive cardiomyopathy. Lancet 2: 490-493
20. Krum H, Schwartz B, Sackner-Bernstein J et al 1993 Double-blind placebo controlled study on the long-term efficacy of carvedilol. Patients with severe heart failure treated with converting-enzyme inhibitors (Abstract). J Am Coll Cardiol 21 (Suppl A): 114A
21. Leung W, Lau C, Wong C, Chang C, Tai Y, Lim S 1990 Improvement in exercise performance and hemodynamics via labetolol in patients with dilated cardiomyopathy. Am Heart J 119: 884-890
22. Lichstein E, Hager WD, Gregory JJ, Fleiss JL, Rolintzky LM, Bigger JT 1990 Relation between beta adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure in the Multicenter Diltiazem Post Infarction Research Group. J Am Coll Cardiol 16: 1327-1332
23. Maisel A 1993 Treatment of heart failure with metoprolol; beneficial immunological effects. Circulation 88 (Suppl): 1-105-0553
24. Metra M, B-Aloia A, Panina G, Nardi M, Giubbini R, Dei Cas L 1993 Effective acute and chronic carvedilol on resting and exercise hemodynamics of patients with idiopathic cardiomyopathy (Abstract). J Am Coll Cardiol 21 (Suppl A): 114A
25. Olsen SL, Gilbert EM, Renund G et al 1993 Carvedilol improves symptoms and left ventricular and places with congestive heart failure due to ischemic or idiopathic dilated cardiomyopathy (Abstract). J Am Coll Cardiol 21 (Suppl A): 114A
26. Pallis OG, Gambardalo A, Marazzo G et al 1992 Metabolic and cardiovascular benefits deriving from beta-andrenergic blockade with chronic congestive heart failure. Am Heart J 123: 103-110
27. Pitt V 1992 The role of beta adrenergic blocking agents in preventing sudden cardiac deaths. Circulation 85 (Suppl): I-107-I-111
28. Pollock SG, Lystash J, Tedesco C, Cradock G, Smucker ML 1990 Usefulness of bucindolol for congestive heart failure. Am J Cardiol 66: 607-613
29. Sethi KK, Nair M, Aurora R, Khalilullah M 1990 Oral metoprolol therapy in dilated cardiomyopathy: hemodynamic evidence for improved diastolic function accompanying amelioration of symptoms. Im J Cardiol 29: 317-322
30. The Beta Blocker Pooling Project Research Group The Beta Blocker Pooling Project (BBPP) 1988 Subgroup findings from randomized trials in post infarction trials. Eur Heart J 9: 8-16
31. Waagstein F, Bristow M, Swedberg K et al For the Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group 1993 Beneficial effects of metroprolol in idiopathic dilated cardiomyopathy. Lancet 342: 1441-1446
32. Waagstein F, Hjalmarson Å, Varnauskas E, Wallentin I 1975 Effect of chronic beta adrenergic receptor blockade and congestive cardiomyopathy. Br Heart J 37: 1022-1036
33. Wisenbaugh T, Katz I, Davies J et al 1993 Long-term (three months) effects of a new beta blocker (Nebivolol). A cardiac performance in dilated cardiomyopathy. J Am Coll Cardiol 21: 1094-1100
34. Woodley SL, Gilbert EM, Anderson JL, O'Connell JB, Deitchman D, Yanowitz FG, Mealey PC, Volkman K, Renlund DG, Bristow MR 1991 Beta blockade with bucindolol in heart failure due to ischemic versus idiopathic dilated cardiomyopathy. Circulation 84: 2426-2441
35. Woodley SL, Gilbert EM, Anderson JL et al 1991 Beta blockade with bucindolol in heart failure caused by ischemic versus idiopathic dilated cardiomyopathy. Circulation 84: 2426-2441